SEQIRUS USA INC - INFLUENZA VIRUS VACCINE FOR THE 2025-2026 SEASON. FOR THE INMATE POPULATION AT FCI JESUP, GA. PRICE AND TERMS PER CONTRACT# 36E79725D0006. RP#0094-25, LARGE BUSINESS NET 30 - DELIVER TO MEDICAL ASAP
Key Details
Description
INFLUENZA VIRUS VACCINE FOR THE 2025-2026 SEASON. FOR THE INMATE POPULATION AT FCI JESUP, GA. PRICE AND TERMS PER CONTRACT# 36E79725D0006. RP#0094-25, LARGE BUSINESS NET 30 - DELIVER TO MEDICAL ASAP
Context & Analysis
On Nov 18, 2025, Department of Justice obligated $1,762.92 to SEQIRUS USA INC for influenza virus vaccine for the 2025-2026 season. for the inmate population at fci jesup, ga. price and terms per contract# 36e79725d0006. rp#0094-25, large business net 30 - deliver to medical asap. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in SUMMIT, NJ. This award is one of several similar procurements from Department of Justice under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
MCKESSON NON-CONTROLLED DOS: NOV 1- CR MARCH 14, 2024
MCKESSON CORPORATION
$29.2M
MCKESSON: NON-CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU DECEMBER 31, 2025.
MCKESSON CORPORATION
$10.0M
PPV PHARMACEUTICAL ITEMS - FISCAL YEAR 25 PROCUREMENT OF PHARMACEUTICALS ON THE PPV
MCKESSON CORPORATION
$5.3M
MCKESSON STANDARD MEDICATION FY 2025
MCKESSON CORPORATION
$4.4M
MCKESSON STANDARD MEDICATION FY 2025
MCKESSON CORPORATION
$4.4M
Stay Updated
Get notified about new opportunities matching your interests.